Wyeth Pharmaceuticals India Private Limited

Wyeth Pharmaceuticals India Private Limited - business services in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH2006PTC159507 Incorporated 03 February 2006 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company business services
Data last updated
Revenue · FY 2025
₹50.63 Lakh
▲ 37% YoY
Net profit · FY 2025
₹30.1 Lakh
Net margin 59.5%
EBITDA · FY 2025
₹42.93 Lakh
EBITDA margin 84.8%
Authorised capital
₹7 Cr
Registered with MCA
Paid-up capital
₹6.7 Cr
Issued & subscribed
Company age
20 yrs
Est. 2006
Directors on board
2
As per MCA filings
GST registrations
1
None active

About Wyeth Pharmaceuticals India Private Limited

Data last updated:

Wyeth Pharmaceuticals India Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Wyeth (Asia) Limited. It operates in the business support services segment of the business services sector. It was incorporated on 03 February 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2006PTC159507. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹7 Cr and a paid-up capital of ₹6.7 Cr. It was formerly known as Wyeth Pharmaceuticals India Limited. It is led by directors Darshak Pradip Bhagat and Prajeet Nair.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at The Capital 1802 / 1901 Plot No. C – 70 G – Block Bandra Kurla Complex Bandra (East), Mumbai, Maharashtra, India – 400051.

As per the financials filed for FY 2025, the company reported a revenue of ₹50.63 Lakh, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹30.1 Lakh (net margin 59.5%) and EBITDA of ₹42.93 Lakh (EBITDA margin 84.8%). Revenue has grown at a compounded annual rate (CAGR) of 65% over three years and 11% over five years.

Court records list 2 cases involving the company, including 2 filed by the company; 2 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24230MH2006PTC159507
Registration Number 159507
Incorporation Date 03 February 2006
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Wyeth (Asia) Limited
Compliance Status Active Compliant

CIN history

Wyeth Pharmaceuticals India has one previous CIN (Corporate Identification Number): U24230MH2006PLC159507. The current CIN is U24230MH2006PTC159507, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230MH2006PTC159507Current
U24230MH2006PLC159507Previous

Contact details

Wyeth Pharmaceuticals India Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    The Capital 1802 / 1901 Plot No. C – 70 G – Block Bandra Kurla Complex Bandra (East), Mumbai, Maharashtra, India – 400051
  • Industry
    Business Services, Business Support Services

To see the full contact details of Wyeth Pharmaceuticals India Private Limited, buy the company report.

Comprehensive company report
Wyeth Pharmaceuticals India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Wyeth Pharmaceuticals India is administrative and support service activities. In detail, this covers office administrative, office support and other business support activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
NAdministrative and support service activities82Office administrative, office support and other business support activities

To see the full business activity and turnover split of Wyeth Pharmaceuticals India Private Limited, buy the company report.

Financials of Wyeth Pharmaceuticals India Private Limited

FY 2025 filings available

Wyeth Pharmaceuticals India Private Limited reported revenue of ₹50.63 Lakh (up 37% YoY) for FY 2025.

Revenue · FY 2025
₹50.63 Lakh ▲ 37%
Net profit · FY 2025
₹30.1 Lakh margin 59.5%
EBITDA · FY 2025
₹42.93 Lakh margin 84.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 65%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 681%
5 years · compounded
▲ 14%

Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 37% growth in the latest year. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹42.93 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹30.1 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin84.8%
Net Profit Margin59.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Wyeth Pharmaceuticals India Private Limited, buy the company report.

Board of directors of Wyeth Pharmaceuticals India Private Limited

Wyeth Pharmaceuticals India has 2 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Darshak Pradip BhagatDirector30 Mar 20206 Years 7 MonthsCurrent
Prajeet NairDirector07 May 201511 Years 5 MonthsCurrent

Auditor

Wyeth Pharmaceuticals India Private Limited is audited by B S R & Co. LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
B S R & Co. LLPFY 2023101248W /W-100022

Shareholding

The shareholding of Wyeth Pharmaceuticals India Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Wyeth Pharmaceuticals India Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Wyeth Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Wyeth Pharmaceuticals India has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Wyeth Pharmaceuticals India Private Limited, buy the company report.

Recent activity

Wyeth Pharmaceuticals India Private Limited has 18 board changes on record since 2007: 2 appointments and 16 cessations. The latest: Darshak Pradip Bhagat ceased to be Additional Director on 30 Dec 2020.

AGM
Wyeth Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Wyeth Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Darshak Pradip Bhagat ceased to be Additional Director.
Ceased
Samir Salauddin Kazi ceased to be Director.
Appointed
Darshak Pradip Bhagat was appointed as Director.
Ceased
Durga Anand Gadgil ceased to be Director.
Ceased
Prajeet Nair ceased to be Additional Director.
Ceased
Neema Thakore ceased to be Director.
Appointed
Prajeet Nair was appointed as Director.
Ceased
Chandrashekhar Nilkanth Potkar ceased to be Director.
Ceased
Pragnesh Harkisandas Shah ceased to be Director.
Ceased
Manish Damji Shah ceased to be Director.

9 earlier events are in the company report.

Frequently asked questions

Wyeth Pharmaceuticals India is an active private limited company based in Mumbai, Maharashtra, India. The company works in business support services, within the business services industry. It was incorporated on 03 February 2006 (20+ years old) and is registered under CIN U24230MH2006PTC159507.

Wyeth Pharmaceuticals India has 2 current directors:

The latest financial statements of Wyeth Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

No. Wyeth Pharmaceuticals India has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Wyeth Pharmaceuticals India is U24230MH2006PTC159507. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Wyeth Pharmaceuticals India has 2 court cases on record: 2 filed by the company. 2 are pending.

Wyeth Pharmaceuticals India was incorporated on 03 February 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.

Darshak Pradip Bhagat ceased to be Additional Director on 30 Dec 2020. Samir Salauddin Kazi ceased to be Director on 31 Mar 2020. Darshak Pradip Bhagat was appointed as Director on 30 Mar 2020. Wyeth Pharmaceuticals India has 18 board changes on record in total.

The registered office of Wyeth Pharmaceuticals India is at The Capital 1802 1901 Plot No. C – 70 G – Block Bandra Kurla Complex Bandra East, Mumbai, Maharashtra, India – 400051.

Wyeth Pharmaceuticals India operates in the business services industry, in the business support services segment.